Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Ribo-seq Optimization to Gain Insights into Protein Production

Ribosome profiling, a gene sequencing approach, has increased the understanding of the human genome by uncovering previously undiscovered protein-coding regions.

22 Sep 2023

Newly Discovered Fungus Helps Destroy a Harmful Food Toxin

Patulin is a harmful mycotoxin produced by fungi typically found in damaged fruits, including apples, pears, and grapes.

1 Sep 2023

Altered Anti-Nausea Drug can Penetrate Cells and Provide Sustained Pain Relief

Altering the chemical properties of an anti-nausea drug enables it to enter an interior compartment of the cell and provide long-lasting pain relief, according to a new study led by researchers at NYU College of Dentistry's Pain Research Center.

23 May 2023

Dengue Viruses Subvert Mosquito Biology to Tamp Down Human Immune Responses

The saliva of mosquitoes infected with dengue viruses contains a substance that thwarts the human immune system and makes it easier for people to become infected with these potentially deadly viruses, new research reveals.

5 Apr 2023

Small group of airway neurons plays a key role in alerting the brain about infection

A new study led by researchers at Harvard Medical School illuminates how the brain becomes aware that there is an infection in the body.

9 Mar 2023

Study reveals important role of Secretin receptor in regulating drinking behavior under thirst

Animals instinctively find and consume water when feeling thirsty in order to restore body fluid osmolality and plasma volume to their set points.

15 Feb 2023

Importance of drying temperature in the technological properties of OSPF

Orange, starchy sweet potatoes are great mashed, cut into fries or just roasted whole. But you likely haven't considered grinding them into a flour and baking them into your next batch of cookies -; or at least, not yet!

14 Feb 2023

Salivary miRNAs may be a promising biomarker for persistent post-concussive symptoms in children

Predicting clinical recovery of children with concussion is challenging. While concussion symptoms typically resolve within one to three weeks, up to one-third of children develop persistent post-concussive symptoms (PPCS), including headache, nausea, dizziness, blurred vision and sensitivity to light and/or sound.

26 Oct 2022

New study supports bradykinin storm theory of COVID-19's viral pathogenesis

A new paper published in Nature Communications adds further evidence to the bradykinin storm theory of COVID-19's viral pathogenesis -; a theory that was posited two years ago by a team of researchers at the Department of Energy's Oak Ridge National Laboratory.

19 Sep 2022

Improving your Canna-business

In this interview, PerkinElmer, talks to AZoLifeSciences about how you can go about improving your canna-business.

From PerkinElmer 7 Sep 2022

Study shows how drugs help to treat hepatitis A virus replication using an animal model

A virus must go through the viral replication cycle in order to propagate throughout the body and cause disease.

5 Jul 2022

Research shows the molecular pathways for trichrome formation and cannabis production

Many compounds known as cannabinoids are found in cannabis, a plant that is receiving more and more attention for its extensive medical potential.

27 Jun 2022

The Native Antigen Company Expands Range of Norovirus-Like Particles

The Native Antigen Company today announced the expansion of its norovirus-like particle range, with the addition of six new reagents.

From The Native Antigen Company 13 Jan 2022

People previously infected by Chikungunya virus may develop partial immunity to Mayaro virus

A study conducted at the University of São Paulo (USP) in Brazil suggests people previously infected by Chikungunya virus may develop partial immunity to Mayaro virus.

6 Dec 2021

Study reveals what causes T cells to be non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

1 Nov 2021